- Home
- SAGE vs MFH Comparison
SAGE vs MFH Comparison
Compare SAGE & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- MFH
- Stock Information
- Founded
- SAGE 2010
- MFH 2011
- Country
- SAGE United States
- MFH United States
- Employees
- SAGE N/A
- MFH N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- MFH Finance: Consumer Services
- Sector
- SAGE Health Care
- MFH Finance
- Exchange
- SAGE Nasdaq
- MFH Nasdaq
- Market Cap
- SAGE 462.2M
- MFH 394.2M
- IPO Year
- SAGE 2014
- MFH N/A
- Fundamental
- Price
- SAGE $5.61
- MFH $5.60
- Analyst Decision
- SAGE Hold
- MFH
- Analyst Count
- SAGE 19
- MFH 0
- Target Price
- SAGE $11.53
- MFH N/A
- AVG Volume (30 Days)
- SAGE 1.1M
- MFH 167.7K
- Earning Date
- SAGE 02-12-2025
- MFH 12-05-2024
- Dividend Yield
- SAGE N/A
- MFH N/A
- EPS Growth
- SAGE N/A
- MFH N/A
- EPS
- SAGE N/A
- MFH N/A
- Revenue
- SAGE $106,399,000.00
- MFH $716,863.00
- Revenue This Year
- SAGE N/A
- MFH N/A
- Revenue Next Year
- SAGE $122.78
- MFH N/A
- P/E Ratio
- SAGE N/A
- MFH N/A
- Revenue Growth
- SAGE 837.60
- MFH 119.50
- 52 Week Low
- SAGE $4.62
- MFH $1.03
- 52 Week High
- SAGE $28.26
- MFH $8.07
- Technical
- Relative Strength Index (RSI)
- SAGE 50.27
- MFH 49.20
- Support Level
- SAGE $4.94
- MFH $5.59
- Resistance Level
- SAGE $5.91
- MFH $7.50
- Average True Range (ATR)
- SAGE 0.36
- MFH 0.82
- MACD
- SAGE 0.02
- MFH -0.23
- Stochastic Oscillator
- SAGE 69.07
- MFH 0.34
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a digital fintech company powered by blockchain technology. The company's scope of business includes digital asset trading, asset digitization, cross-border remittance, and other services, providing compliant, professional, and efficient digital financial services to its customers. The group is also engaged in Bitcoin mining, digital currency investment, and trading, continuing its expansion to online and traditional brokerage services and other related fields.